x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Ophthalmology Journal

American Academy of Ophthalmology

Join Ophthalmology"s social media editors as they interview authors and editors of the American Academy of Ophthalmology"s journal family: Ophthalmology, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science.

health & fitness medicine

All Episodes

17:37

Type 2 Diabetes Medications and Glaucoma Risk

Ophthalmology Journal ·

2025/01/30

How do GLP-1 receptor agonists and metformin affect glaucoma risk in patients with Type 2 diabetes? Join Dr. Ike Ahmed and Jawad Muayad as they discuss the data on diabetes treatments and glaucoma risk with Dr. Emily Schehlein. From their Ophthalmology article, “Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.” Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients

en

12:41

Blood Pressure and Glaucoma Progression

Ophthalmology Journal ·

2025/01/16

What is the relationship between blood pressure and visual field progression? Can systemic arterial blood pressure be used to assess the risk of glaucomatous progression? Dr. Emily Schehlein finds out from Dr. David S. Greenfield, author of Ophthalmology’s “Relationship between Blood Pressure and Rates of Glaucomatous Visual Field Progression: The Vascular Imaging in Glaucoma Study.” Relationship between Blood Pressure and Rates of Glaucomatous Visual Field Progression. Donkor, Richard et al

en

23:25

Risk of Recurrence in Acute Anterior Uveitis

Ophthalmology Journal ·

2025/01/02

What are the risk factors and frequency of recurrence in patients with acute anterior uveitis? Dr. Edmund Tsui and Dr. Rachael L. Niederer delve into the findings of her recent Ophthalmology study, “Risk of Recurrence in Acute Anterior Uveitis.” Risk of Recurrence in Acute Anterior Uveitis. Brodie, James T. et al. Ophthalmology, Volume 131, Issue 11, 1281 – 1289.

en

25:41

Seasonal Effects on Corneal Immune Cells

Ophthalmology Journal ·

2024/12/19

People regularly deal with seasonal allergies, but how much do these environmental factors affect our corneas? Dr. Matt Feng sits down with Dr. Laura Downie to discuss her recent Ophthalmology article, “Intravital Imaging of the Human Cornea Reveals the Differential Effects of Season on Innate and Adaptive Immune Cell Morphodynamics.” Intravital Imaging of the Human Cornea Reveals the Differential Effects of Season on Innate and Adaptive Immune Cell Morphodynamics. Wu, Mengliang et al

en

17:45

Peer Review in Ophthalmology and the Council of...

Ophthalmology Journal ·

2024/12/05

Why is peer review important? Is AI changing peer review? How can you become a better peer reviewer? Find out in this special episode, with our newest host and Social Media Editor, Dr. Emily Schehlein, and Dr. Matilda F. Chan. Dr. Chan, in collaboration with editors of several ophthalmic and optometric journals and the National Eye Institute, administers the new Council of Vision Editors Fellow Program designed to train early career vision scientists on the peer-review process. The Academy’s family

en

19:08

Plasma Exchange in Optic Neuritis Hospitalizations

Ophthalmology Journal ·

2024/11/21

Dr. Drew Carey interviews Dr. John J. Chen on the trends and use patterns of plasma exchange therapy for optic neuritis, from his Ophthalmology article, “Trends in Plasma Exchange Use in Optic Neuritis Hospitalizations in the United States.” Trends in Plasma Exchange Use in Optic Neuritis Hospitalizations in the United States. Akosman, Sinan et al. Ophthalmology, Volume 131, Issue 10, 1207 – 1214.

en

28:09

cfDNA in Ocular Histiocytosis

Ophthalmology Journal ·

2024/11/07

Dr. Rajesh Rao speaks with Dr. Jasmine H. Francis on whether sequencing of plasma-derived ctDNA can noninvasively diagnose ocular-involving histiocytosis. From her Ophthalmology Science article, “Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis.” Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis. Francis, Jasmine H. et al. Ophthalmology Science, Volume 4, Issue 5.

en

15:12

AI for Pediatric Pseudopapilledema and True Papilledema

Ophthalmology Journal ·

2024/10/24

Can artificial intelligence distinguish between pseudopapilledema and true papilledema in children? Dr. Drew Carey interviews author Dr. Melinda Y. Chang on whether AI can be used to improve the diagnostic process in children with abnormal optic nerves and concern for elevated intracranial pressure. From her Ophthalmology Science article, “Artificial Intelligence to Differentiate Pediatric Pseudopapilledema and True Papilledema on Fundus Photographs” Artificial Intelligence to Differentiate

en

24:38

Evaluating Primary Treatment for People with Advanced...

Ophthalmology Journal ·

2024/10/10

Does primary trabeculectomy or medical treatment produce better outcomes in terms of quality of life, clinical effectiveness, and safety in patients with advanced glaucoma? Dr. Drew Carey interviews Dr. Anthony J. King on the results of his recent study asking this question published in Ophthalmology, “Evaluating Primary Treatment for People with Advanced Glaucoma: Five-Year Results of the Treatment of Advanced Glaucoma Study.” Evaluating Primary Treatment for People with Advanced Glaucoma. King,

en

28:28

Ophthalmology Education in Medical Schools

Ophthalmology Journal ·

2024/09/26

How has ophthalmology medical education changed over time in medical school curriculums? Dr. Edmund Tsui speaks with Drs. Ashish Agar and Sascha Spencer on their review of global trends in medical school ophthalmology education from their Ophthalmology article, “A Systematic Review of Ophthalmology Education in Medical Schools: The Global Decline.” A Systematic Review of Ophthalmology Education in Medical Schools. Spencer, Sascha K.R. et al. Ophthalmology, Volume 131, Issue 7, 855 – 863. Join

en

28:33

Adverse Events with Opioids and Ophthalmic Surgery

Ophthalmology Journal ·

2024/09/12

Ophthalmologists are not spared from the opioid epidemic. Recent studies have shown that opioids continue to be prescribed after ophthalmic surgeries. Dr. Drew Carey interviews Dr. Matthew R. Starr on his retrospective study published in Ophthalmology, “Hospitalization, Overdose, and Mortality After Opioid Prescriptions Tied to Ophthalmic Surgery.” Hospitalization, Overdose, and Mortality After Opioid Prescriptions Tied to Ophthalmic Surgery. Thao, Viengneesee et al. Ophthalmology, Volume 131, Issue

en

23:41

CRISPR Assay for Fungal Keratitis

Ophthalmology Journal ·

2024/08/29

The RID-MyC assay, a CRISPR/Cas12a-based test, offers swift and reliable detection of Fungal Keratitis, enhancing diagnostic capabilities at point-of-care settings. Dr. Rajesh Rao interviews Dr. Siddharth Narendran on the development of this assay from his Ophthalmology Science article, “Development and Clinical Evaluation of a CRISPR/Cas12a-Based Nucleic Acid Detection Platform for the Diagnosis of Keratomycoses.” Development and Clinical Evaluation of a CRISPR/Cas12a-Based Nucleic Acid Detection

en

23:19

Bevacizumab in High-Risk Penetrating Keratoplasty

Ophthalmology Journal ·

2024/08/15

Dr. Matt Feng is joined by Dr. Thomas H. Dohlman to discuss the effectiveness of topical and subconjunctival bevacizumab in suppressing vascularization in graft and host bed after high-risk corneal transplantation, from his Ophthalmology Science article “Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation” Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation. Dohlman,

en

24:31

Hearing Dysfunction with Teprotumumab

Ophthalmology Journal ·

2024/08/01

What does hearing dysfunction have to do with an ophthalmology podcast? Listen up and find out as Dr. Drew Carey interviews Dr. Jamie A. Keen and Dr. Erin M. Shriver on the risks of using teprotumumab to hearing function in treatment of thyroid eye disease. From their article “Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab.” Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab. Keen, Jamie A. et al. Ophthalmology, Volume 131, Issue

en

23:59

Recurrent Retinal Redetachment after Cataract Surgery

Ophthalmology Journal ·

2024/07/18

Dr. Matt Feng interviews Drs. Bita Momenaei and Jason Hsu on the incidence, timing, risk factors, and outcomes of recurrent retinal detachment after phacoemulsification, from their Ophthalmology Retina article, “Incidence and Outcomes of Recurrent Retinal Detachment after Cataract Surgery in Eyes with Prior Retinal Detachment Repair.” Incidence and Outcomes of Recurrent Retinal Detachment after Cataract Surgery in Eyes with Prior Retinal Detachment Repair. Momenaei, Bita et al. Ophthalmology Retina,

en

27:46

Private Equity & Ophthalmology: Spending and Services...

Ophthalmology Journal ·

2024/06/20

Private equity (PE) firms acquired over 200 ophthalmology and optometry practices in the United States from 2021 through 2019. Dr. Rajesh Rao interviews author Dr. Gary Joseph Lelli about the implications of this trend and influence of PEs on care use and spending, from his Ophthalmology article, “Association of Private Equity Firm Acquisition of Ophthalmology Practices with Medicare Spending and Use of Ophthalmology Services.” Association of Private Equity Firm Acquisition of Ophthalmology

en

20:02

Efficacy of Carbonic Anhydrase in Patients with...

Ophthalmology Journal ·

2024/06/06

X-linked retinoschisis is a relatively common inherited retinal degenerative disease that almost exclusively affects males. No curative medical therapy is available for this condition, however topical and oral carbonic anhydrase inhibitors have been used for the management of cystoid fluid collections. Dr. Drew Carey interviews authors Dr. Jonathan Hensman and Dr. Camiel J.F. Boon on the results of their Ophthalmology Retina article, “Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid

en

16:44

Aqueous Macrophages Contribute to Conserved CCL2 &...

Ophthalmology Journal ·

2024/05/23

Uveitis is a heterogenous group of inflammatory eye diseases for which current cytokine-targeted immune therapies are effective for only a subset of patients. Dr. Edmund Tsui is joined by Dr. Lynn M. Hassman and MD/PhD student Joseph B. Lin to explore potential common underlying mechanisms that exist for immune cell recruitment in uveitis in their Ophthalmology Science article, “Aqueous macrophages contribute to conserved CCL2 and CXCL10 gradients in uveitis” Aqueous Macrophages Contribute to

en

17:03

Vitamin A Deficiency Retinopathy

Ophthalmology Journal ·

2024/05/09

Vitamin A deficiency is the leading cause of preventable childhood blindness worldwide, but how does this deficiency present itself in a clinical setting? Dr. Drew Carey finds out as he interviews Dr. Nieraj Jain, author of “Characteristics of Vitamin A Deficiency Retinopathy at a Tertiary Referral Center in the United States.” Characteristics of Vitamin A Deficiency Retinopathy at a Tertiary Referral Center in the United States. Levine, David A. et al. Ophthalmology Retina, Volume 8, Issue 2, 126 -

en

35:19

Outcomes and Complications after IOL Exchange

Ophthalmology Journal ·

2024/04/25

An analysis of the IRIS® Registry shows IOL exchanges are increasing over time with vision improving 60% of the time, but worse visual outcomes associated with greater age, worse baseline vision, Black race, Hispanic ethnicity, Medicaid insurance, smoking, and concurrent vitrectomy. Dr. Matt Feng sits with authors Drs. David F. Chang and Fasika A. Woreta to discuss these findings and more from their Ophthalmology article, “Visual Acuity Outcomes and Complications after Intraocular Lens Exchange: An

en

95 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown